Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients.
J Transl Med
; 18(1): 121, 2020 03 11.
Article
in En
| MEDLINE
| ID: mdl-32160899
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nivolumab
/
Melanoma
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Transl Med
Year:
2020
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom